Paul Rennie's comments on Wednesday in his interview with Andrew Scott of Proactive were very positive. At 1:10 he said a number of 'commercial companies' had contacted Paradigm to wish them well and wanting to 'have further communications'.
They will have had access to the same announcments we've seen about Paradigm's exclusivity of supply of PPS from Bene. I'd assume any serious suitor might be able to do due diligence on the agreement if they thought it necessary.
Time for a big pharma deal, page-19
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |